Literature DB >> 20394735

Endogenous hydrogen sulfide is involved in the pathogenesis of atherosclerosis.

Wang Qiao1, Tang Chaoshu, Jin Hongfang, Du Junbao.   

Abstract

Atherosclerosis is a chronic, complex, and progressive pathological process in large and medium sized arteries. The exact mechanism of this process remains unclear. Hydrogen sulfide (H(2)S), a novel gasotransmitter, was confirmed as playing a major role in the pathogenesis of many cardiovascular diseases. It plays a role in vascular smooth muscle cell (VSMC) proliferation and apoptosis, participates in the progress of hyperhomocysteinemia (HHCY), inhibits atherogenic modification of LDL, interferes with vascular calcification, intervenes with platelet function, and there are interactions between H(2)S and inflammatory processes. The role of H(2)S in atherosclerotic pathogenesis highlights the mysteries of atherosclerosis and inspires the search for innovative therapeutic strategies. Here, we review the studies to date that have considered the role of H(2)S in atherosclerosis. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20394735     DOI: 10.1016/j.bbrc.2010.04.061

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Regulatory effects of hydrogen sulfide on alveolar epithelial cell endoplasmic reticulum stress in rats with acute lung injury.

Authors:  Zhi-Wei Liu; Hai-Ying Wang; Lan Guan; Bin Zhao
Journal:  World J Emerg Med       Date:  2015

Review 2.  The role of perivascular adipose tissue in vascular smooth muscle cell growth.

Authors:  Chao-Yu Miao; Zhi-Yong Li
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

Review 3.  The Impact of H2S on Obesity-Associated Metabolic Disturbances.

Authors:  Ferran Comas; José María Moreno-Navarrete
Journal:  Antioxidants (Basel)       Date:  2021-04-21

4.  Hydrogen sulfide inhibits the development of atherosclerosis with suppressing CX3CR1 and CX3CL1 expression.

Authors:  Huili Zhang; Changfa Guo; Duojiao Wu; Alian Zhang; Ting Gu; Liansheng Wang; Changqian Wang
Journal:  PLoS One       Date:  2012-07-18       Impact factor: 3.240

5.  Protective role of hydrogen sulfide against noise-induced cochlear damage: a chronic intracochlear infusion model.

Authors:  Xu Li; Xiao-Bo Mao; Ren-Yi Hei; Zhi-Bin Zhang; Li-Ting Wen; Peng-Zhi Zhang; Jian-Hua Qiu; Li Qiao
Journal:  PLoS One       Date:  2011-10-26       Impact factor: 3.240

6.  A novel hypothesis for atherosclerosis as a cholesterol sulfate deficiency syndrome.

Authors:  Stephanie Seneff; Robert M Davidson; Ann Lauritzen; Anthony Samsel; Glyn Wainwright
Journal:  Theor Biol Med Model       Date:  2015-05-27       Impact factor: 2.432

Review 7.  H2S biosynthesis and catabolism: new insights from molecular studies.

Authors:  Peter Rose; Philip K Moore; Yi Zhun Zhu
Journal:  Cell Mol Life Sci       Date:  2016-11-14       Impact factor: 9.261

8.  Defining the minimally effective dose and schedule for parenteral hydrogen sulfide: long-term benefits in a rat model of hindlimb ischemia.

Authors:  John William Langston; Christopher F Toombs
Journal:  Med Gas Res       Date:  2015-04-16

Review 9.  Hydrogen sulfide and translational medicine.

Authors:  Wei Guo; Ze-Yu Cheng; Yi-Zhun Zhu
Journal:  Acta Pharmacol Sin       Date:  2013-10       Impact factor: 6.150

10.  Hydrogen Sulfide Up-Regulates the Expression of ATP-Binding Cassette Transporter A1 via Promoting Nuclear Translocation of PPARα.

Authors:  Dong Li; Qinghui Xiong; Jin Peng; Bin Hu; Wanzhen Li; Yizhun Zhu; Xiaoyan Shen
Journal:  Int J Mol Sci       Date:  2016-04-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.